Role of blue-light cystoscopy in the management of non-muscle invasive bladder cancer

被引:0
|
作者
Pignot, G. [1 ]
机构
[1] Univ Paris Sud, Hop Bicetre, Serv Urol, F-94270 Le Kremlin Bicetre, France
来源
PROGRES EN UROLOGIE | 2015年 / 25卷 / 10期
关键词
Non-muscle invasive bladder cancer; Cystoscopy; Diagnosis; Recurrence; Cost-effectiveness; Indications; GUIDED FLUORESCENCE CYSTOSCOPY; CARCINOMA IN-SITU; PHOTODYNAMIC DIAGNOSIS; COST-EFFECTIVENESS; FOLLOW-UP; COST/BENEFIT/THERAPEUTIC VALUE; TRANSURETHRAL RESECTION; FLEXIBLE CYSTOSCOPY; MUSCLE; RECURRENCE;
D O I
10.1016/j.purol.2015.05.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Blue-light cystoscopy aims to facilitate the detection of bladder tumors in order to optimize the completeness of resection. We performed a literature analysis using data from Medline and according to PRISMA guidelines. Several meta-analyses have confirmed the interest of the blue-light cystoscopy in terms of improved detection rate and disease-free survival compared to standard white-light cystoscopy. These benefits outweigh the initial costs related to the acquisition of specific equipment, allowing an improvement in quality-adjusted life-years and a reduction of costs over time. Indications vary according to guidelines and must take into account equipment and logistic constraints on each center. The objective of this article is to make a focus on the role and the interest of blue-light cystoscopy in the management of NMIBC in 2015. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:607 / 615
页数:9
相关论文
共 50 条
  • [21] Blue versus white light for transurethral resection of non-muscle invasive bladder cancer
    Bellut, L.
    Kunath, F.
    UROLOGIE, 2022, 61 (04): : 411 - 414
  • [22] Blue versus white light for transurethral resection of non-muscle invasive bladder cancer
    Maisch, Philipp
    Koziarz, Alex
    Vajgrt, Jon
    Narayan, Vikram
    Ha Kim, Myung
    Dahm, Philipp
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (12):
  • [23] Blue light cystoscopy delays time to recurrence in non-muscle invasive bladder cancer patients treated in a real-world setting
    Daneshmand, S.
    Bivalacqua, T. J.
    Holzbeierlein, J. M.
    Kaimakliotis, H. Z.
    Konety, B.
    Liao, J. C.
    Pohar, K.
    Steinberg, G. D.
    Taylor, J. M.
    Tyson, M. D.
    Willard, B.
    Joshi, S.
    Gore, J. G.
    Lotan, Y. L.
    Porten, S. P.
    Kates, M.
    Kenny, R. K.
    Chad, M. C.
    Seyedian, S. S. Ladi
    Alsyouf, M.
    EUROPEAN UROLOGY, 2023, 83
  • [24] Update on the management of non-muscle invasive bladder cancer
    Aldousari, Saad
    Kassouf, Wassim
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2010, 4 (01): : 56 - 64
  • [25] NARROW BAND IMAGING CYSTOSCOPY IN NON-MUSCLE INVASIVE BLADDER CANCER - A PROSPECTIVE RANDOMIZED COMPARISON TO THE STANDARD WHITE LIGHT CYSTOSCOPY
    Dogra, Prem Nath
    Desai, Pragnesh
    Singh, Prabhjot
    JOURNAL OF UROLOGY, 2016, 195 (04): : E137 - E137
  • [26] Blue-light cystoscopy's effects on management of bladder cancer when compared to traditional white-light cystoscopy
    Mount, Andrew
    Williams, Stephen Bentley
    Dinney, Colin P. N.
    Grossman, H. Barton
    Pettaway, Curtis Alvin
    Chapin, Brian Francis
    Navai, Neema
    Matin, Surena F.
    Graber, William F.
    Kamat, Ashish M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [27] THE ROLE OF REPEAT TRANSURETHRAL RESECTION IN THE MANAGEMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
    Rolevich, A. I.
    Sukonko, O. G.
    Krasny, S. A.
    Strotsky, A. V.
    ONKOUROLOGIYA, 2010, 6 (01): : 59 - 64
  • [28] Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA
    Siamak Daneshmand
    Anne K. Schuckman
    Bernard H. Bochner
    Michael S. Cookson
    Tracy M. Downs
    Leonard G. Gomella
    H. Barton Grossman
    Ashish M. Kamat
    Badrinath R. Konety
    Cheryl T. Lee
    Kamal S. Pohar
    Raj S. Pruthi
    Matthew J. Resnick
    Norm D. Smith
    J. Alfred Witjes
    Mark P. Schoenberg
    Gary D. Steinberg
    Nature Reviews Urology, 2014, 11 : 589 - 596
  • [29] Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA
    Daneshmand, Siamak
    Schuckman, Anne K.
    Bochner, Bernard H.
    Cookson, Michael S.
    Downs, Tracy M.
    Gomella, Leonard G.
    Grossman, H. Barton
    Kamat, Ashish M.
    Konety, Badrinath R.
    Lee, Cheryl T.
    Pohar, KamalS.
    Pruthi, Raj S.
    Resnick, Matthew J.
    Smith, Norm D.
    Witjes, J. Alfred
    Schoenberg, Mark P.
    Steinberg, Gary D.
    NATURE REVIEWS UROLOGY, 2014, 11 (10) : 589 - 596
  • [30] NBI Cystoscopy in Non-Muscle Invasive Bladder Cancer: A Prospective Comparison to the Standard Approach
    Geavlete, B.
    Jecu, M.
    Geavlete, P.
    UROLOGY, 2012, 80 (03) : S213 - S213